Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model. Inclusion in the federal program reinforces the Company's commitment to helping providers improve behavioral health outcomes while making solutions more affordable for patients.

As part of the collaboration, Syra Health and HealthSync will work together to engage healthcare providers and support patient referrals into ACCESS and ACCESS-aligned programs, using Syrenity as the enabling behavioral health solution. Together, the companies aim to expand access to coordinated behavioral health services and improve outcomes for individuals enrolled in Original Medicare. Syra Health's partnership with HealthSync remains subject to negotiation and the execution of a definitive agreement between the parties.

Syrenity is Syra Health's award-winning digital mental and behavioral health solution designed to improve behavioral and mental health outcomes. In a clinical research study conducted by Indiana University, Syrenity demonstrated reductions in depression and anxiety symptoms and improvements in overall well-being for those with access to Syrenity when compared to those without access.

"Inclusion in the CMS ACCESS model program represents what we believe can become a durable, ten-year revenue engine for Syra Health," said Greg Alexander, CEO of Syra Health. "We expect this federal government model to enable scaled deployment of Syrenity across behavioral health populations, where prescribers can be reimbursed for referring patients and patients gain continuous, affordable access to prevention-first digital behavioral health support."

The CMS ACCESS model is designed to advance innovative approaches to healthcare delivery and reimbursement, with an emphasis on improving patient outcomes, expanding access, and accelerating value-based care. Syra Health's participation aligns with its broader mission to deliver prevention-focused, affordable, and accessible healthcare solutions that improve outcomes across diverse populations.

About Syra Health

Syra Health is an integrated healthcare solutions company serving government and commercial healthcare organizations with innovative solutions designed to improve health outcomes. We specialize in healthcare prevention, expanding access, and delivering affordable solutions. Our healthcare analytics provide proactive, actionable insights and data-driven intelligence, and our HIPAA-compliant, fully accessible, and award-winning digital health solutions enable measurable health outcomes in highly regulated healthcare environments. Through training and education, we help healthcare organizations reduce costs and deliver consistent, high-quality care. Discover our healthcare solutions at www.syrahealth.com and follow the Company on LinkedIn.

About HealthSync

To empower healthcare professionals with cutting-edge, data-driven insights and real-time analytics, enhancing clinical decision-making and improving patient outcomes through innovative technology, seamless integration, and unwavering support. For more information, please visit www.healthsync.live.

Forward-Looking Statements

 Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy, the risk that the Company will not be able to enter into a definitive agreement with HealthSync on favorable terms, or at all, and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2025, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact

Christine Drury

IR/PR
Syra Health

[email protected]

317-385-9227

SOURCE Syra Health